These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 15593306)

  • 1. Selective recognition of enzymatically active prostate-specific antigen (PSA) by anti-PSA monoclonal antibodies.
    Michel S; Collomb-Clerc E; Geourjon C; Charrier JP; Passagot J; Courty Y; Deléage G; Jolivet-Reynaud C
    J Mol Recognit; 2005; 18(3):225-35. PubMed ID: 15593306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of human prostate-specific antigen in a sandwich antibody complex.
    Stura EA; Muller BH; Bossus M; Michel S; Jolivet-Reynaud C; Ducancel F
    J Mol Biol; 2011 Dec; 414(4):530-44. PubMed ID: 22037582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of prostate-specific antigen binding peptides selected by phage display technology.
    Ferrieu-Weisbuch C; Michel S; Collomb-Clerc E; Pothion C; Deléage G; Jolivet-Reynaud C
    J Mol Recognit; 2006; 19(1):10-20. PubMed ID: 16312021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of enzymatically active prostate-specific antigen (PSA) in the extracellular fluid of primary human prostate cancers and human prostate cancer xenograft models.
    Denmeade SR; Sokoll LJ; Chan DW; Khan SR; Isaacs JT
    Prostate; 2001 Jun; 48(1):1-6. PubMed ID: 11391681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of prostate specific antigen and alpha1-antichymotrypsin interaction using antipeptide monoclonal antibodies.
    Michel S; Charrier JP; Deleage G; Battail-Poirot N; Jolivet M; Jolivet-Reynaud C
    J Urol; 2001 Jan; 165(1):301-6. PubMed ID: 11125429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of a ternary complex between human prostate-specific antigen, its substrate acyl intermediate and an activating antibody.
    Ménez R; Michel S; Muller BH; Bossus M; Ducancel F; Jolivet-Reynaud C; Stura EA
    J Mol Biol; 2008 Feb; 376(4):1021-33. PubMed ID: 18187150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization and anti-angiogenic properties of prostate-specific antigen isoforms in seminal fluid.
    Mattsson JM; Valmu L; Laakkonen P; Stenman UH; Koistinen H
    Prostate; 2008 Jun; 68(9):945-54. PubMed ID: 18386289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separation of enzymatically active and inactive prostate-specific antigen (PSA) by peptide affinity chromatography.
    Wu P; Stenman UH; Pakkala M; Närvänen A; Leinonen J
    Prostate; 2004 Mar; 58(4):345-53. PubMed ID: 14968435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-free prostate-specific antigen monoclonal antibody epitopes defined by mimotopes and molecular modeling.
    Michel S; Deléage G; Charrier JP; Passagot J; Battail-Poirot N; Sibai G; Jolivet M; Jolivet-Reynaud C
    Clin Chem; 1999 May; 45(5):638-50. PubMed ID: 10222350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A structural model for the prostate disease marker, human prostate-specific antigen.
    Villoutreix BO; Getzoff ED; Griffin JH
    Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunization.
    Leinonen J; Niemelä P; Lövgren J; Bocchi L; Pettersson K; Nevanlinna H; Stenman UH
    J Immunol Methods; 2004 Jun; 289(1-2):157-67. PubMed ID: 15251421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments.
    Väisänen V; Peltola MT; Lilja H; Nurmi M; Pettersson K
    Anal Chem; 2006 Nov; 78(22):7809-15. PubMed ID: 17105175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro affinity maturation of an anti-PSA antibody for prostate cancer diagnostic assay.
    Muller BH; Savatier A; L'Hostis G; Costa N; Bossus M; Michel S; Ott C; Becquart L; Ruffion A; Stura EA; Ducancel F
    J Mol Biol; 2011 Dec; 414(4):545-62. PubMed ID: 22019475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.
    Peracaula R; Tabarés G; Royle L; Harvey DJ; Dwek RA; Rudd PM; de Llorens R
    Glycobiology; 2003 Jun; 13(6):457-70. PubMed ID: 12626390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein.
    Corey E; Buhler KR; Vessella RL
    Urology; 1997 Oct; 50(4):567-71; discussion 571-2. PubMed ID: 9338733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of human glandular kallikrein hK2 from LNCaP cells.
    Grauer LS; Charlesworth MC; Saedi MS; Finlay JA; Liu RS; Kuus-Reichel K; Young CY; Tindall DJ
    J Androl; 1996; 17(4):353-9. PubMed ID: 8889697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), alpha-1-antichymotrypsin (ACT), and the PSA-ACT complex.
    Wan XS; Xu YA; Ware JH; Kennedy AR
    Prostate; 2003 Jul; 56(2):131-41. PubMed ID: 12746838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells.
    Väisänen V; Lövgren J; Hellman J; Piironen T; Lilja H; Pettersson K
    Prostate Cancer Prostatic Dis; 1999 Mar; 2(2):91-97. PubMed ID: 12496845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and purification of recombinant active prostate-specific antigen from Escherichia coli.
    Jeong S; Lee SW
    J Microbiol Biotechnol; 2007 May; 17(5):840-6. PubMed ID: 18051307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
    Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
    Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.